Research Library — Clinical Trials — Page 3 | Reta Compare

73 research articles in Clinical Trials. Page 3 of 3.

Articles

• Recent Findings on Retatrutide's Efficacy in Diabetes Management
• Retatrutide Shows Promising A1C Reduction and Weight Loss in Phase 3 Trial
• Advancements in Retatrutide for Type 2 Diabetes Management
• Exploring the Efficacy of Retatrutide in Diabetes Management
• Retatrutide's Phase III Trials Show Potential in Type 2 Diabetes Management
• Retatrutide Demonstrates Significant Weight Loss and A1C Reductions in Phase III Diabetes Trial
• Exploring Retatrutide's Role in Osteoarthritis Management: Insights from TRIUMPH-4
• Insights on Retatrutide Trial Results and Their Implications
• Exploring the Potential of Retatrutide in Chronic Kidney Disease Management
• Exploring Clinician Perspectives on Retatrutide's Promising Data
• Retatrutide Shows Promising Results in Obesity and Knee Osteoarthritis Clinical Trials
• Positive Phase III Trial Results for Retatrutide Enhance Its Research Potential
• Eli Lilly's Retatrutide Shows Promising Results in Late-Stage Obesity Trials
• Eli Lilly's Phase 3 Trial Results Highlight Retatrutide's Potential in Obesity Treatment
• Eli Lilly's Retatrutide: Insights Ahead of Upcoming Trial Results
• Retatrutide Demonstrates Efficacy in Reducing UACR and Enhancing eGFR in Obesity
• Retatrutide Shows Promise in Mitigating Cancer Progression Linked to Obesity
• Eli Lilly to Present Early Data on Retatrutide, a Next-Generation Weight Loss Drug
• Retatrutide's Role in Treating Metabolic Dysfunction-Associated Steatotic Liver Disease
• Eli Lilly Advances Retatrutide in Phase III Trials for Obesity Management
• Retatrutide Shows Promising Results in Recent Weight Loss Trials
• Retatrutide's Potential Role in Resolving Non-Alcoholic Fatty Liver Disease
• Retatrutide: Insights from a Phase 1b Trial of a Novel Triple Receptor Agonist